{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:11:32Z","timestamp":1791666692526,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vaccine.2024.06.060","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T05:00:39Z","timestamp":1719637239000},"page":"126093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3979-4616","authenticated-orcid":false,"given":"Geert V.T.","family":"Roozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob S.","family":"van Binnendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerco","family":"den Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meta","family":"Roestenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.E.","family":"Roukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2024.06.060_b0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2023.05.019","article-title":"Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach","volume":"152","author":"Greenhawt","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.06.060_b0010","unstructured":"Official data collated by Our World in Data \u2013 processed by Our World in Data. \u201cCOVID vaccine dosis by manufacturer\u201d . Official data collated by Our World in Data [original data]. [Accessed 22 May 2024]. Available from: https:\/\/ourworldindata.org\/grapher\/covid-vaccine-doses-by-manufacturer?tab=table."},{"key":"10.1016\/j.vaccine.2024.06.060_b0015","unstructured":"Mikulic M. COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer [Accessed 22 May 2024]. Available from: https:\/\/www.statista.com\/statistics\/1198516\/covid-19-vaccinations-administered-us-by-company\/."},{"issue":"7","key":"10.1016\/j.vaccine.2024.06.060_b0020","article-title":"Verdenking op allergische reactie op COVID-19 vaccinatie: praktische overwegingen. Dutch Journal for","volume":"31","author":"Meertens","year":"2021","journal-title":"Dermatol Venereol"},{"issue":"31","key":"10.1016\/j.vaccine.2024.06.060_b0025","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2024.06.060_b0030","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/all.15241","article-title":"Allergies and COVID-19 vaccines: An ENDA\/EAACI Position paper","volume":"77","author":"Barbaud","year":"2022","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.060_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/all.15571","article-title":"Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis","volume":"78","author":"Greenhawt","year":"2023","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.060_b0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.anai.2022.05.004","article-title":"Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose","volume":"129","author":"Van Meerbeke","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.060_b0045","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.7326\/M22-2089","article-title":"Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study","volume":"175","author":"Roozen","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.060_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00785-w","article-title":"Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial","volume":"9","author":"Prins","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.06.060_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2024.03.028","article-title":"Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose","author":"Roozen","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"18","key":"10.1016\/j.vaccine.2024.06.060_b0060","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.vaccine.2009.02.049","article-title":"Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy","volume":"27","author":"Roukens","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.060_b0065","unstructured":"Dutch National Center for Coordination of Travelers Advise (LCR). Yellow Fever LCR protocol. 2017."},{"key":"10.1016\/j.vaccine.2024.06.060_b0070","unstructured":"SPEAC. SO2- D2.5.2.1 \u2013 AESI Case Definition Companion Guide for 1st Tier AESI - Anaphylaxis. 2021 Available from: www.speacsafety.net\/services\/anaphylaxis-companion-guide\/."},{"issue":"9","key":"10.1016\/j.vaccine.2024.06.060_b0075","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiaa479","article-title":"SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence","volume":"222","author":"den Hartog","year":"2020","journal-title":"J Infect Dis"},{"issue":"6576","key":"10.1016\/j.vaccine.2024.06.060_b0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2024.06.060_b0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jech-2020-215678","article-title":"Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave","volume":"75","author":"Vos","year":"2020","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.060_b0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-022-00432-w","article-title":"Extended interval BNT162b2 vaccination enhances peak antibody generation","volume":"7","author":"Parry","year":"2022","journal-title":"npj Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T18:55:56Z","timestamp":1726167356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":18,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0264410X24007345"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126093"}}